Table 5.
Feature | Patients, n (%) |
---|---|
Renal tubular acidosis | |
Prevalence (n = 2005) | 186 (9) |
Female:male ratio (n = 208) | 27:1 |
Age at diagnosis, years (n = 208) | 41 |
RTA classification (n = 321) | |
Type I (distal RTA) | 313 (97) |
Type II (proximal RTA/Fanconi syndrome) | 8 (3) |
Symptomatic presentation (n = 130) | |
Hypokalaemic weakness/paralysis | 90 (69) |
Renal colics | 23 (12) |
Radiological nephrocalcinosis | 33 (17) |
Osteomalacia | 26 (13) |
Polyuria/polydipsia | 7 (4) |
Renal failure (creatinine >1.3 mg/dl) (n = 198) | 47 (24) |
Renal biopsy (n = 321) | 149 (46) |
Histopathological features (n = 149) | |
Interstitial nephritis | 140 (94) |
Other features | 9 (6) |
Immunological profile | |
Anti-Ro (n = 225) | 160 (71) |
Anti-La (n = 215) | 116 (54) |
GN | |
Prevalence (n = 2005) | 78 (4) |
Female:male ratio (n = 81) | 19:1 |
Age at diagnosis, years (n = 81) | 53 |
Clinical presentation (n = 76) | |
Oedema/nephrotic syndrome | 23 (22) |
Laboratory abnormalities | 43 (78) |
Laboratory abnormalities | |
Renal failure (creatinine >1.3 mg/dL) (n = 72) | 36 (50) |
24 h proteinuria >0.5 g (n = 36) | |
0.5–1 g | 4 (11) |
1–1.5 g | 7 (19.5) |
>1.5 g | 25 (69.5) |
Haematuria (n = 68) | 35 (51) |
Renal biopsy (n = 321) | 149 (46) |
Histopathological features (n = 149) | |
Membranoproliferative GN | 47 (38) |
Mesangial proliferative GN | 29 (23) |
Membranous glomerulonephritis | 28 (22) |
Focal segmental glomerulonephritis | 21 (17) |
Crescentic rapidly progressive GN | 9 (7) |
IgA nephropathy | 7 (6) |
Glomeruloesclerosis | 2 (2) |
Minimal change nephropathy | 2 (2) |
Thin basement membrane nephropathy | 1 (1) |
GN not specified | 3 (2) |
Immunological profile | |
Anti-Ro (n = 65) | 47 (72) |
Anti-La (n = 65) | 29 (45) |
Cryoglobulins (n = 56) | 29 (52) |
ANCA (n = 16) | 8 (50) |
Variables were not detailed in all studies and the prevalence of a specific feature is stated as the number of cases with that feature/number of cases in which the feature was detailed. RTA: renal tubular acidosis.